Report in 48 hours
Booked 0 times
TUMOUR PANEL (FEMALE)
Comprehensive Cancer Marker Screening for Women.
Sample Type
blood
Fasting Required
No
Description
A Tumour Panel (Female) is a diagnostic test designed to identify and measure specific markers related to various cancers affecting women. This panel typically includes markers for breast cancer, ovarian cancer, cervical cancer, and other female-specific cancers. It helps detect the presence of cancerous cells, assess the extent of the disease, and monitor treatment efficacy.
Covid Safety
Assured
Free Report
Counselling
Recommended for You
How our test process works!
Overview
- Purpose: It helps assess a woman's genetic predisposition to certain cancers and can guide personalized treatment or preventive care options.
- Genes Tested: The panel typically tests for several key genes, such as BRCA1, BRCA2 (associated with breast and ovarian cancer), TP53, and others related to various cancers.
- Cancer Risk: Identifies genetic mutations that may increase the risk of developing cancers such as breast, ovarian, uterine, and others. This test can provide an assessment of inherited cancer risk.
Risk Assessment
- Genetic Mutations: Some mutations, such as BRCA1/2 mutations, significantly increase the risk of breast and ovarian cancers. These mutations are inherited and can be passed down through generations.
- Personalized Recommendations: Based on the results, healthcare providers may recommend increased monitoring, preventive surgeries (like mastectomy or oophorectomy), or targeted therapies if a woman is found to be at a higher risk.
- Family History: A family history of certain cancers may increase the likelihood of a woman carrying genetic mutations related to those cancers.
Normal Range
- Normal Range: For genetic testing, "normal" usually means no significant mutations or alterations in the genes being tested. Variations outside of the normal sequence might suggest a genetic predisposition, but not all variants are necessarily harmful.
Interpretation
- Positive Results: If a mutation is detected, it may indicate an increased risk of certain cancers. In some cases, it might suggest the need for further testing, increased screening, or prophylactic measures.
- Negative Results: A negative result means no significant genetic mutations were found. However, this does not mean the individual is free of cancer risk, as many factors (including lifestyle, environmental exposures) can also contribute to cancer development.
- Variants of Unknown Significance (VUS): Sometimes, the test might identify genetic changes whose significance is not fully understood. These results may require follow-up with genetic counseling or additional testing.
Sample Type
- Sample Type: Blood, saliva, or cheek swab are common sample types for tumor panels. The most common method is a blood sample, which provides DNA that is analyzed in the lab.
Frequently Asked Question
The Tumor Panel (Female) test is a diagnostic tool used to detect genetic mutations or biomarkers associated with various cancers in women. It analyzes specific genes and proteins that are linked to the development of tumors, helping identify the risk of cancer or monitor its progression.
This test helps in the early detection of cancers such as breast, ovarian, cervical, and endometrial cancers by identifying genetic mutations or abnormal markers that could indicate the presence of these cancers. Early detection often improves treatment outcomes and survival rates.
Women with a family history of cancers, those experiencing unexplained symptoms like abnormal bleeding or lumps, or individuals at high risk due to genetic factors may be advised to undergo this test. It is also used to monitor individuals undergoing cancer treatment.
The test detects specific genetic mutations, such as BRCA1 and BRCA2 (associated with breast and ovarian cancers), as well as other tumor markers like HER2, which can help assess the type of cancer, its aggressiveness, and the most effective treatment options.
The test is typically performed using a blood or tissue sample. A healthcare provider will collect a sample, which is then sent to a laboratory where it is analyzed for specific genetic mutations or biomarkers.
The results may indicate whether genetic mutations or cancer biomarkers are present. If mutations are found, it may suggest an increased risk of cancer or the presence of cancer cells. A healthcare provider will discuss the results and recommend further testing or treatment options if needed.
Report in 48 hours
Booked 0 times
TUMOUR PANEL (FEMALE)
Comprehensive Cancer Marker Screening for Women.
Offered by other labs
Sample Type
blood
Fasting Required
No
Description
A Tumour Panel (Female) is a diagnostic test designed to identify and measure specific markers related to various cancers affecting women. This panel typically includes markers for breast cancer, ovarian cancer, cervical cancer, and other female-specific cancers. It helps detect the presence of cancerous cells, assess the extent of the disease, and monitor treatment efficacy.
Covid Safety
Assured
Free Report
Counselling